Author(s):
Noor Mohammed Obaid, Zinah Abd Ulelah Abd Ali, Mahmood Shakir Al-Zaidi
Email(s):
noor-mohammed@esraa.edu.iq
DOI:
10.52711/0974-360X.2023.00343 
Address:
Noor Mohammed Obaid1*, Zinah Abd Ulelah Abd Ali1, Mahmood Shakir Al-Zaidi2
1Al Esraa University, College of Pharmacy.
1Department of Chemistry and Biochemistry, Al Nahrain University, College of Medicine, Baghdad, Iraq.
2Department of Medicine, Al Nahrain University, College of Medicine, Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 16,
Issue - 5,
Year - 2023
ABSTRACT:
Background: Diabetes mellitus (DM) is a group of diseases characterized by high blood glucose levels resulting from a defect in the body's ability to produce and/or use insulin. It is believed that oxidative stress plays important role in the development of vascular complications in type 2 diabetes Objectives: to determine the serum concentrations of endogenous melatonin and superoxide dismutase(SOD) in cases of Type 2 DM and compare it with normal controls and to assess the correlation between melatonin and SOD. Materials and methods: A case control study was done on 70 patients with diabetes mellitus type 2 according to ADA definition of DM type 2 recruited from Al Imamain Al-Kathemeaain medical city, Baghdad, Iraq who compared with 70 age, BMI and gender matched healthy control group in the levels of serum melatonin, serum superoxide dismutase (SOD), fasting blood glucose (FBG) level, glycated hemoglobin (HbA1c), lipid profile, serum urea and serum creatinine. Results: the activities of SOD enzyme were significantly (p=0.037) lower than those of controls which is accompanied with a significant reduction in the melatonin levels in patients comparing with controls with a significant positive correlation between GPX activity and melatonin levels in both patients and control groups. Conclusions: melatonin levels showed to be reduced significantly in diabetic patient which may play an essential role in reducing the defense mechanism against ROS via affecting the activity of GPx enzyme.
Cite this article:
Noor Mohammed Obaid, Zinah Abd Ulelah Abd Ali, Mahmood Shakir Al-Zaidi, Association of Melatonin and superoxide dismutase enzyme in patients with type 2 Diabetes Mellitus. Research Journal of Pharmacy and Technology 2023; 16(5):2091-5. doi: 10.52711/0974-360X.2023.00343
Cite(Electronic):
Noor Mohammed Obaid, Zinah Abd Ulelah Abd Ali, Mahmood Shakir Al-Zaidi, Association of Melatonin and superoxide dismutase enzyme in patients with type 2 Diabetes Mellitus. Research Journal of Pharmacy and Technology 2023; 16(5):2091-5. doi: 10.52711/0974-360X.2023.00343 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-5-2
REFERENCES:
1. Hazaratali Panari, Vegunarani M. Study on Complications of Diabetes Mellitus among the Diabetic Patients. Asian J. Nur. Edu. and Research. 2016; 6(2): 171-182. doi: 10.5958/2349-2996.2016.00032.X
2. Parsa P, Ahmadinia-Tabesh R, Mohammadi Y. Assessment of the risk of Coronary Heart Disease in Diabetes Patients Type-II. Asian J. Nursing Education and Research. 2019; 9(2):267-270. doi: 10.5958/2349-2996.2019.00057.0
3. Bhardwaj J, Choudhary R, Sharma P. A comparative study on quality of life among type 1 and type 2 diabetes mellitus clients at selected hospitals of district Mohali, Punjab. Asian J. Nursing Education and Research. 2018; 8(1): 152-158. doi: 10.5958/2349-2996.2018.00032.0
4. Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: An overview. Avicenna J Med. 2020 Oct 13;10(4):174-188. doi: 10.4103/ajm.ajm_53_20. PMID: 33437689; PMCID: PMC7791288.
5. Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M. 16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S244-S253. doi: 10.2337/dc22-S016. PMID: 34964884.
6. Bansal AK, Bilaspuri GS. Impacts of oxidative stress and antioxidants on semen functions. Vet Med Int. 2010;2010:686137.
7. Selvakumar K, Madhan R, Srinivasan G. Baskar V. Antioxidant Assays in Pharmacological Research. Asian J. Pharm. Tech. 2011;1(4): 99-103.
8. Jaydeokar AV, Bandawane DD, SS Nipate , Chaudhari PD. Natural Antioxidants: A Review on Therapeutic Applications. Research J. Pharmacology and Pharmacodynamics. 2012; 4(1): 55-61.
9. Bright F, Raj PS, Amala K, Asokan N, Bel GLA. Free Radical - A Sword with two Edges. Asian J. Research Chem. 2021; 14(2):139-144. doi: 10.5958/0974-4150.2021.00026.2
10. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058-70.
11. Kushwaha SP, Rawat SK, Pavan Kumar P, Tripathi K. Coupling Antioxidant and Antidiabetic assets of 2, 4-Thiazolidinedione Derivatives. Asian J. Pharm. Ana. 2011; 1(4):71-73.
12. Lakshmana G, Chitra V, Kumar DR, Reddy P D, Srinivasan R, Devi G R. Study of Antidiabetic and Free Radical Scavenging Activity of the Methanolic and N-Hexane Extract of Asystasiagangetica Leaf in Alloxan Induced Diabetic Rats. Research Journal of Pharmacology and Pharmacodynamics. 2014; 6(2): 86-93.
13. Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45-63.
14. Pattabiraman K, Muthukumaran P. Antidiabetic and Antioxidant Activity of Morinda tinctoria roxb Fruits Extract in Streptozotocin-Induced Diabetic Rats. Asian J. Pharm. Tech. 2011;1(2): 34-39.
15. Chakraborty P, Kumar S, Dutta D, Gupta V. Role of Antioxidants in Common Health Diseases. Research J. Pharm. and Tech. 2009; 2(2): 238-244.
16. Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4(2):89-96.
17. Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm J. 2016; 24(5): 547-553. doi: 10.1016/j.jsps.2015.03.013.
18. Madi M, Babu S, Kumari S, Shetty S, Achalli S, Madiyal A, Bhat M. Status of Serum and Salivary Levels of Superoxide Dismutase in Type 2 Diabetes Mellitus with Oral Manifestations: A Case Control Study. Ethiop J Health Sci. 2016; 26(6): 523-532. doi: 10.4314/ejhs.v26i6.4.
19. Awni N, Ahmed TS, Sarhat ER, Ali NH, Abass KS. Altered serum levels of melatonin, antioxidant enzymes and oxidative stress in individuals with diabetes mellitus type 2. Revista Latino Americana De Hipertensión, 2022;17(2): 138–141. doi:10.5281/zenodo.6842619.
20. Reiter RJ, Tan DX, Rosales-Corral S, Galano A, Zhou XJ, Xu B. Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions. Molecules. 2018;23(2):509. doi: 10.3390/molecules23020509.
21. Boutin JA. Quinone reductase 2 as a promising target of melatonin therapeutic actions. Expert OpinTher Targets. 2016;20(3):303-17. doi: 10.1517/14728222.2016.1091882.
22. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res. 2011;51(1):1-16. doi: 10.1111/j.1600-079X.2011.00916.x.
23. Barberino RS, Menezes VG, Ribeiro AEAS, Palheta RC Jr, Jiang X, Smitz JEJ, Matos MHT. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity. Biol Reprod. 2017;96(6):1244-1255. doi: 10.1093/biolre/iox053.
24. Deng SL, Sun TC, Yu K, Wang ZP, Zhang BL, Zhang Y, Wang XX, Lian ZX, Liu YX. Melatonin reduces oxidative damage and upregulates heat shock protein 90 expression in cryopreserved human semen. Free Radic Biol Med. 2017 Dec;113:347-354. doi: 10.1016/j.freeradbiomed.2017.10.342.
25. Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L. Melatonin as an antioxidant: under promises but over delivers. J Pineal Res. 2016;61(3):253-78. doi: 10.1111/jpi.12360.
26. Ghosh AK, Naaz S, Bhattacharjee B, Ghosal N, Chattopadhyay A, Roy S, Reiter RJ, Bandyopadhyay D. Mechanism of melatonin protection against copper-ascorbate-induced oxidative damage in vitro through isothermal titration calorimetry. Life Sci. 2017;180:123-136. doi: 10.1016/j.lfs.2017.05.022.